CD48 is a key molecule of immunomodulation affecting prognosis in glioma.
Onco Targets Ther
; 12: 4181-4193, 2019.
Article
in En
| MEDLINE
| ID: mdl-31213836
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Onco Targets Ther
Year:
2019
Document type:
Article